Latest News & Features
Americas
Novartis has revealed plans to sell the dermatology business and generic US oral solids portfolios of its subsidiary Sandoz US to India-based Aurobindo for $900 million. 6 September 2018
Americas
US-based Gilead announced Tuesday, September 4 that it has entered into a licensing agreement with biotech company Trianni for an undisclosed sum. 6 September 2018
Big Pharma
International law firm Simmons & Simmons has hired a new IP team to boost its office in Milan. 5 September 2018
Americas
Italy-based research organisation IRBM has signed a new agreement with Merck & Co in the peptides therapeutics area, extending the parties’ long-standing collaboration. 5 September 2018
Big Pharma
The European Medicines Agency has reportedly put a stop to the UK’s role in evaluating new EU medicines for sale as Brexit looms. 4 September 2018
Asia
The Bombay High Court has imposed Rs 1.5 crore of costs on a pharmaceutical company which infringed India-based Glenmark Pharmaceuticals’ trademarks. 3 September 2018
Americas
A former GSK researcher has pleaded guilty to conspiring to steal trade secrets, in what prosecutors said was a scheme to benefit a Chinese pharmaceutical company. 3 September 2018
Americas
A proposal in the North American Free Trade Agreement to set the length of biologic data exclusivity at ten years would harm patients, according to generic associations. 31 August 2018
Americas
A report released this week by non-profit MassBio has shown that Massachusetts companies “dominated” the landscape for US initial public offerings (IPOs) of biotech companies in 2017. 31 August 2018
Americas
Life sciences company Emergent BioSolutions announced plans to acquire Adapt Pharma earlier this week, in what the company said was an effort to combat the public health threat from opioid overdose. 30 August 2018